Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shionogi & Company is a Japanese pharmaceutical company dedicated to the research and development of innovative medicines. The company researches, develops, manufactures, and markets pharmaceuticals addressing global health issues, with key focuses on infectious diseases, pain management, and neurological disorders. Shionogi is committed to enhancing the quality of life for patients worldwide through scientific innovation.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shionogi & Company is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shionogi & Company last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at 114.81 JPY.
Across its last 4 earnings reports, Shionogi & Company stock moved by ±9.7% on average the following day. The largest reaction was +27.1% on 10/27/2025; 1 of 4 reactions were positive.
Shionogi & Company has beaten analyst EPS estimates in 3 of its last 3 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.